Barclays PLC Exact Sciences Corp Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$42.43 - $70.83 $2.89 Million - $4.82 Million	-68,000 Reduced 97.14%	2,000 $136,000
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $1.96 Million - $3.53 Million	-47,500 Reduced 40.43%	70,000 $2.96 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $6.61 Million - $8.67 Million	117,500 New	117,500 $8.12 Million
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $1.7 Million - $2.43 Million	17,100 Added 271.43%	23,400 $3.1 Million
Q2 2020 Aug 12, 2020	SELL	$55.75 - $92.75 $9.2 Million - $15.3 Million	-165,000 Reduced 96.32%	6,300 $548,000
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $360,050 - $992,180	-9,500 Reduced 5.25%	171,300 $9.94 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $6.42 Million - $8.25 Million	82,700 Added 84.3%	180,800 $16.7 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $3.06 Million - $4.15 Million	33,900 Added 52.8%	98,100 $8.87 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $680,276 - $897,104	-7,600 Reduced 10.58%	64,200 $7.58 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $7.69 Million - $12 Million	-124,000 Reduced 63.33%	71,800 $6.22 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $4.18 Million - $6.17 Million	74,600 Added 61.55%	195,800 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $1.86 Million - $3.11 Million	-38,600 Reduced 24.16%	121,200 $9.57 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $2.05 Million - $3.79 Million	54,200 Added 51.33%	159,800 $9.56 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $907,896 - $1.31 Million	22,800 Added 27.54%	105,600 $4.26 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $5.38 Million - $7 Million	-115,700 Reduced 58.29%	82,800 $4.35 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $7.35 Million - $9.35 Million	198,500	198,500 $9.35 Million

Others Institutions Holding EXAS

# of Institutions

674

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.08 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$959 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$868 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$731 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$405 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account